Product Information

PROPYLTHIOURACIL 50 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.2829 per EA under NDC 00480924201. Its NADAC has been published 117 times since Aug 28, 2024.

FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is BD.

PROPYLTHIOURACIL 50 MG TABLET

Propylthiouracil
$0.2829per EA

Strength

50 mg/1

NDC

00480924201

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

PROPYLTHIOURACIL

Approval Type

Generic (ANDA)

FDA Application

ANDA080172

FDA Approved

Before 1982

TE Code

BD

On Market Since

7/10/2024

Pharmacological Classes

Thyroid Hormone Synthesis Inhibitor
Thyroid Hormone Synthesis Inhibitors

Price Statistics

The NADAC for PROPYLTHIOURACIL 50 MG TABLET has been published 117 times since Aug 28, 2024, and over the history we have for it it has risen 15.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2829 per EA
All-time high$0.3341 (Jul 16, 2025)
All-time low$0.2433 (Nov 20, 2024)
52-week high$0.2847
52-week low$0.2646
Median price$0.2808
Average price$0.2866
Largest weekly change+25.4% (Sep 18, 2024)
Weeks tracked117
Tracking sinceAug 28, 2024

Price History

1W

+5.0%

1M

+5.3%

3M

+4.7%

6M

-0.7%

1Y

+6.9%

3Y

N/A

5Y

N/A

All

+15.7%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 4% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of PROPYLTHIOURACIL 50 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for PROPYLTHIOURACIL 50 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.2829 per EA (NDC 00480924201), effective Nov 18, 2026.

How has the price of PROPYLTHIOURACIL 50 MG TABLET changed over time?

Over the history we have for it, the NADAC for PROPYLTHIOURACIL 50 MG TABLET has risen 15.7%. It has been tracked across 117 weekly CMS publications since Aug 28, 2024.

What are the highest and lowest recorded NADAC prices for PROPYLTHIOURACIL 50 MG TABLET?

Since Aug 28, 2024, the NADAC for PROPYLTHIOURACIL 50 MG TABLET has ranged from a low of $0.2433 (Nov 20, 2024) to a high of $0.3341 (Jul 16, 2025), with a median of $0.2808 per EA.

Are there cheaper alternatives to PROPYLTHIOURACIL 50 MG TABLET?

Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, PROPYLTHIOURACIL 50 MG TABLET, is $0.2724 per EA — about 4% below PROPYLTHIOURACIL 50 MG TABLET.

Who manufactures PROPYLTHIOURACIL 50 MG TABLET?

PROPYLTHIOURACIL 50 MG TABLET (NDC 00480924201) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.